GenFleet Therapeutics prices 13,600,000-share H-share placement at HK$ 34.69 each

• GenFleet Therapeutics (Shanghai) agreed a private placement of 13,600,000 new H shares at HK$ 34.69 each.
• Deal size HK$ 471.8 million gross; HK$ 466.9 million net; pricing implies a 9.71% discount to the prior close.
• New shares equal 3.67% of shares outstanding pre-deal; 3.54% on an enlarged basis.
• Morgan Stanley, CLSA to place shares on a best-efforts basis to at least six investors; closing targeted for July 17, 2026.
• Proceeds earmarked mainly for R&D, including RAS pipeline programs; remainder for platform upgrades, working capital, general corporate uses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics (Shanghai) Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260715-12244466), on July 14, 2026, and is solely responsible for the information contained therein.